| Noninvasive administration of protein antigens: transdermal immunization with bovine serum albumin in transfersomes A Paul, G Cevc Vaccine Research 4 (3), 145-164, 1995 | 88 | 1995 |
| Use of heat-labile toxin of enterotoxigenic Escherichia coli to facilitate mucosal immunization RI Walker Vaccine Research. 2, 1-10, 1993 | 45 | 1993 |
| Immunization with peptide heteroconjugates primes a T helper cell type 1-associated antibody (IgG2a) response that recognizes the native epitope on the 38-kDa protein of … DH Zimmerman, S Morris, D Rouse, KFW Worthington, DA Elliott, ... Vaccine research 5 (2), 103-118, 1996 | 43 | 1996 |
| Induction of immune recognition of self-epidermal growth factor II: characterization of the antibody response and the use of a fusion protein G González, OL Pardo, A Lage, B Sanchez, JL GARCIA, I BEAUSOLEIL Vaccine research 6 (2), 91-100, 1997 | 37 | 1997 |
| Induction of human cytotoxic T cell lines directed against point-mutated p21 ras-derived synthetic peptides KY Tsang, CA Nieroda, R De Filippi, YK Chung, H Yamaue, JW Greiner, ... Vaccine Research 3 (4), 183-193, 1994 | 37 | 1994 |
| Synthetic Conjugates Capable of Activating T Cells HZ DANIEL, KF BERGMANN, KS ROSENTHAL, DA ELLIOTT Vaccine research 5 (2), 1996 | 36 | 1996 |
| A pilot study demonstrating the feasibility of using intratumoral vaccinia injections as a vector for gene transfer MJ Mastrangelo, HC Maguire, P McCue, SS Lee, A Alexander, ... Vaccine Research 4 (2), 55-69, 1995 | 34 | 1995 |
| Induction of immune recognition of self epidermal growth factor (EGF): effect on EGF-biodistribution and tumor growth G González, B Sánchez, E Suárez, I Beausoleil, O Perez, M Lastre Vaccine research 5 (4), 233-244, 1996 | 33 | 1996 |
| Enhanced immune response to an intradermally delivered DNA vaccine expressing a secreted form of BHV-1 gD R Braun, L Babiuk, S Van Drunen Littel-Van den Hurk Vaccine research 6 (3), 151-164, 1997 | 31 | 1997 |
| Immunization of melanoma patients with antiidiotypic monoclonal antibody BEC2 (which mimics GD3 ganglioside): pilot trials using no immunological adjuvant PB Chapman, PO Livingston, ME Morrison, L Williams, AN Houghton Vaccine Research 3 (2), 59-70, 1994 | 31 | 1994 |
| A formalinized toxoid for protection of mice from inhaled ricin JF Hewetson, VR Rivera, PV Lemley, ML Pitt, DA Creasia, WL Thompson Vaccine Research 4 (4), 179-188, 1995 | 30 | 1995 |
| Principles of selective inactivation of the viral genome: dependence of the rate of viral RNA modification on the number of protonizable groups in ethyleneimine oligomers EI Budowsky, MA Zalesskaya, NM Nepomnyashchaya, RG Kostyanovsky Vaccine research 5 (1), 29-39, 1996 | 28 | 1996 |
| Protection against monkey-cell grown cell-free HIV-2 challenge in macaques immunized with native HIV-2 envelope glycoprotein gp125 C Nilsson, R Thorstensson, G Gilljam, S Sjolander, K Hild, K Broliden, ... Vaccine Research 4 (3), 165-176, 1995 | 27 | 1995 |
| An adjuvant formulation that preferentially induces T helper cell type 1 cytokine and CD8+ cytotoxic responses is associated with up-regulation of IL-12 and suppression of IL … JM Brewer, CW Roberts, M Conacher, J McColl, BA Blarney, J Alexander Vaccine research 5 (2), 77-89, 1996 | 25 | 1996 |
| Prevention of mother-to-infant transmission of hepatitis B virus with use of a preS2-containing vaccine in Bali, Indonesia IGP SURYA, S Kishimoto, S Sudaryat, F Tsuda, A Hamid, K Takahashi Vaccine research 5 (4), 203-213, 1996 | 20 | 1996 |
| Optimization of antibody responses of a malaria DNA vaccine in Aotus monkeys RA Gramzinski, DC Maris, N Obaldia, R Rossan, M Sedegah, R Wang Vaccine research 5 (3), 173-183, 1996 | 19 | 1996 |
| Prospects and problems for development of a vaccine against diarrhea caused by Campylobacter RL Haberberger Jr, RI Walker Vaccine Research 3 (1), 15-22, 1994 | 17 | 1994 |
| g-Irradiated Viable Tumor Cells as Whole-Cell Vaccines Can Stimulate in Situ Syngeneic Antitumor Cytotoxic T Lymphocytes and Delayed-Type Hypersensitivity Reactivity Whereas … V Schirrmacher, A Griesbach, U Zangemeister-Wittke Vaccine Research 3 (1), 31-48, 1994 | 17 | 1994 |
| Thermostability of poliovirus, measles, and hepatitis B vaccines JL Melnick Vaccine research 4 (1), 1-10, 1995 | 15 | 1995 |
| HIV-1, Not HIV-2, is prevalent in Nigeria: Need for consideration in vaccine plans AG Abimiku, A Zwandor, N Gomwalk, S Kyari, S Opajobi, A Ibanga, ... Vaccine research 3 (2), 101-104, 1994 | 15 | 1994 |
Seyed Davar SiadatPasteur Institute of Iran, Microbiology Research Center, Department of Mycobacteriology andVerified email at pasteur.ac.ir
